Global DNA and gene chips market expected to generate around USD 6.12 billion by 2025, at a CAGR of around 12.5% between 2019 and 2025. DNA and gene chips are also known as DNA microarrays. DNA microarrays are biochips that are used to detect a large number of genes, which are present in a gene sample.
Sarasota, FL -- (SBWIRE) -- 04/16/2019 -- Zion Market Research has published a new report titled "DNA and Gene Chips Market by Type (Oligonucleotide DNA and Complementary DNA), by Product (Consumables and Instruments), by Application (Cancer Diagnosis & Treatment, Gene Expression, Proteomics, Genomics, Drug Discovery, Agricultural Biotechnology, and Others), and by End-User (Academic & Government Research Institutes, Hospitals and Diagnostics Centers, Biotechnology and Pharmaceutical Companies, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025". According to the report, the global DNA and gene chips market was valued at approximately USD 2.68 billion in 2018 and is expected to generate around USD 6.12 billion by 2025, at a CAGR of around 12.5% between 2019 and 2025.
Download Free PDF Research Report Brochure @ https://www.zionmarketresearch.com/requestbrochure/dna-and-gene-chips-market
DNA and gene chips are also known as DNA microarrays. DNA microarrays are biochips that are used to detect a large number of genes, which are present in a gene sample. DNA microarrays are microscopic slides that are made up of thousands of spots present in defined positions. These spots contain particular DNA sequences or DNA genes. This DNA sequence acts as a probe for gene detection and is mainly used to detect large DNA sequences. The rising number of research activities related to gene expression and drug discovery for the treatment of genetic diseases is driving the global DNA and gene chips market.
The market for DNA and gene chips is divided into type, product, application, and end user. By type, the market for DNA and gene chips is bifurcated into oligonucleotide DNA and complementary DNA. Oligonucleotide DNA is anticipated to dominate the market in the future, owing to its high accuracy as compared to complementary DNA.
Based on product, the DNA and gene chips market is fragmented into instruments and consumables. Consumables are predicted to dominate the DNA and gene chips market owing to the constant demand of the consumables because of the growing research activities.
Based on application, the DNA and gene chips market includes gene expression, cancer diagnosis and treatment, proteomics, drug discovery, genomics, agricultural biotechnology, and others. Drug discovery is projected to show a higher growth rate in the future, owing to the increase in research activities for drug development to treat chronic and genetic diseases. The cancer diagnosis and treatment segment dominated the global market for DNA and gene chips, owing to the growing prevalence of cancer and its awareness.
Based on end-user, the market for DNA and gene chips includes hospital and diagnostic centers, academic and government research institutes, biotechnology and pharmaceutical companies, and others. Biotechnology and pharmaceutical companies are anticipated to show a high growth rate in the years ahead, owing to an increase in the establishment of manufacturing units, particularly in developing countries.
By region, North America dominated the DNA and gene chips market globally in 2018, owing to the early introduction of highly developed research equipment, increase in healthcare spending, the presence of highly skilled workforce, and an increase in the number of R&D projects related to gene expression. The Asia Pacific is anticipated to show the highest year-to-year growth over the forecast time period, owing to the growing investments by government and companies for research activities related to the genome, the rising prevalence of cancer, and rapid technological advancements witnessed in the healthcare sector.
Request Free Sample Report @ https://www.zionmarketresearch.com/sample/dna-and-gene-chips-market
Some key players of the global DNA and gene chips market are Perkin Elmer, Inc., Illumina, Inc., Thermo Fisher Scientific, Inc., Macrogen Inc., Agilent Technologies, Greiner Bio-One International GmbH, Asper Biotech, CapitalBio Corporation, Microarrays Inc., Oxford Gene Technology, Arrayit Corporation, and bioMérieux SA.
This report segments the global DNA and gene chips market as follows:
Global DNA and Gene Chips Market: Type Analysis
Oligonucleotide DNA (o-DNA)
Complementary DNA (c-DNA)
Global DNA and Gene Chips Market: Product Analysis
Global DNA and Gene Chips Market: Application Analysis
Cancer Diagnosis and Treatment
Global DNA and Gene Chips Market: End-User Analysis
Academic and Government Research Institutes
Hospitals and Diagnostics Centers
Biotechnology and Pharmaceutical Companies
Inquiry more about this report @ https://www.zionmarketresearch.com/inquiry/dna-and-gene-chips-market
Global DNA and Gene Chips Market: Regional Analysis
The Middle East and Africa